Featured Speakers

Rafi Ahmed, PhD

CRWAD Keynote Speaker

Vaccine Center Director
Emory Vaccine Center

“T Cell Memory and Exhaustion: Implications for Immunotherapy”

Speaker Info

Amesh Adalja, MD, FIDSA

CRWAD Keynote Speaker

Johns Hopkins University Center for Health Security

“The Characteristics of Pandemic Pathogens”

Speaker Info

Scott Dee, DVM, MS, PhD

African Swine Fever Special Symposium Speaker

Director of Pipestone Applied Research

Pipestone Veterinary Services

The risk of feed for viral transport and transmission: What do we know and what can we do

Waithaka Mwangi, PhD

African Swine Fever Special Symposium Speaker

College of Veterinary Medicine

Kansas State University

Prospects for an African Swine Fever Virus Subunit DIVA Vaccine

Raymond “Bob” Rowland, PhD

African Swine Fever Special Symposium Speaker

Professor and Head, Department of Pathobiology

College of Veterinary Medicine

University of Illinois

Novel tools for ASF control and prevention: 7 years’ research in Kansas Biosecurity Research Institute

Paul Sundberg, DVM, PhD, DACVPM

African Swine Fever Special Symposium Speaker

Executive Director

Swine Health Information Center

ASF: US prevention, preparedness and response

Roy Curtiss, PhD

2020 ACVM Distinguished Microbiologist

Department of Infectious Diseases & Immunology

University of Florida Gainsville

“Converting a pathogen to become a servant

Scott McVey, DVM, PhD, DACVM

2020 AAVI Distinguished Veterinary Immunologist

Director, Center for Grain and Animal Health Research

USDA, ARS

A Journey Through Vaccine Valley

Larry Glickman, VMD, DrPH

2020 AVEPM Calvin Schwabe Award Recipient

Professor Emeritus

Department of Comparative Pathobiology

College of Veterinary Medicine

Purdue University

Utilizing big data in veterinary medicine

Shawn Bearson, PhD

Research Microbiologist

USDA, ARS

DIVA vaccine cross-protects against Salmonella serovars in food animals

Alan Beck, ScD

College of Veterinary Medicine

Purdue University

The Biology of the Human-Animal Bond

Jay Calvert, PhD

Zoetis

From Scientific Discovery to Commercial Product in 10 Easy Steps: The Case of CD163 and PRRS Vacccines

Roy Curtiss, PhD

Department of Infectious Diseases & Immunology

University of Florida Gainsville

Vaccine Discovery and Development – from Lab to Market Place

Charlene Edinboro, DVM, PhD

Exponent

“Small Animals – Big Data!”

Thomas Gallagher, PhD

Loyola University Chicago

Host factors controlling susceptibility to coronavirus infections

Cyril G. Gay, DVM, PhD

Senior National Program Leader, Animal Production and Protection

USDA-ARS

” The U.S. National Biodefense Strategy for developing veterinary countermeasures to prepare and respond to biological threat agents.”

Douglas Gladue, PhD

USDA, ARS

Advances in African swine fever live-attenuated vaccines

George Moore, DVM, PhD, DACVIM

Purdue University

“Big Data (Big Benefits or Big Obstacles?)”

Srinand Sreevatsan, BVSC, MVSC, MPH, PhD

Associate Dean for Research and Graduate Studies

Pathobiology and Diagnostic Investigation

Michigan State University

Mycobacterium-host interactions – Lessons from 25 years of research on a slow growing bacterium

John H. Wycoff III. PhD

Director of BioMARC

Colorado State University

“From Discovery to Corporate Development; Challenges between Academia and Commercialization.”

back to top